mindray medical international limited
palo alto, calif. — july 30, 2007— frost & sullivan has selected mindray medical international as the recipient of the 2007 global excellence award in patient monitoring .
) is a leading developer, manufacturer and marketer of medical devices worldwide. mindray maintains its global headquarters in shenzhen ,
mindray medical international limited is a leading developer, manufacturer and marketer of medical devices in china with a significant and growing presence worldwide. established in 1991, mindray offers a broad range of products across three primary business segments: patient monitoring devices, diagnostic laboratory instruments, and ultrasound imaging systems. mindray is headquartered in shenzhen, china, and has 29 local sales and service offices in china, as well as sales and service offices in boston, istanbul, london, mumbai, seattle and vancouver. for more information, please visit urltoken .
mindray, founded in 1991, is a leading global developer, manufacturer, and supplier of medical devices whose mission is to deliver high - quality, richly featured medical products making healthcare more accessible and affordable around the world. mindray provides solutions in three core businesses: patient monitoring and life support, medical imaging, and in - vitro diagnostics .
terms of use | site map | cookie notice | privacy notice | compliance hotline | contact us | © 2017 shenzhen mindray bio - medical electronics co. , ltd. all rights reserved
quality is built into every aspect of mindray’s solutions and influences everything the company does. mindray follows the most stringent international and fda manufacturing and quality control standards in each of its state - of - the art manufacturing facilities, ensuring efficiency and traceability throughout the entire process .
) limited is serving as the financial advisor to the special committee of the board of directors of the company (the
special committee
). shearman & sterling llp is serving as the u. s. legal counsel to the special committee and walkers is serving as the
, its u. s. headquarters in mahwah, new jersey and has multiple sales offices in major international markets. from its main manufacturing and engineering base in china, mindray supplies through its worldwide distribution network a broad range of products across three primary business segments, namely patient monitoring and life support, in - vitro diagnostics, and medical imaging systems. for more information, please visit
as no patient monitoring manufacturer has developed significant manufacturing practices in china for international exports, mindray’s primary competitive advantage is expected to remain intact in the near future ,
adds arani .
on the other hand, as its international market share is expanding, the company continues to build operations closer to its end users, thus providing better quality and efficient services to both its end users and distributors .
mindray has been quite successful at gaining a strong foothold in the international markets in recent years. leveraging its brand recognition, global sales network covering 140 countries through over 800 distributors, world - class r & d platform, and competitively priced products, mindray has gained market share in an impressive array of market demographics .
with corporate headquarters located in shenzhen, china, and 42 international subsidiaries with branch offices in 32 countries, mindray has approximately 7, 500 employees worldwide. eight global r & d centers and an industry leading investment of 10% of annual revenue into research and development further demonstrates mindray’s commitment to innovation and advancing technology in a global market .
today, mindray products and services can be found in healthcare facilities in over 190 countries and regions .
mindray’s products have encountered a higher than average demand in europe, where for the first half of 2006 alone, european sales jumped from 8. 1 percent to 16. 9 percent of revenues. considering the similarity of the western european and the north american markets in terms of demand and competition, similar success in the north american medical imaging and patient monitoring markets is expected .
already a major participant both in established international markets such as germany, the united kingdom, france and italy as well as high - growth emerging markets which include india, russia, and turkey, mindray is poised to play a larger role in the global patient monitoring market. the company has also established an office in mumbai, india this year and offices are scheduled to be set up in five more locations; russia, canada, brazil, mexico, and the netherlands .
another milestone was the 2013 acquisition of ultrasound technology leader zonare medical systems, based in silicon valley, california, solely dedicated to ultrasound excellence through its next generation, software - based zone sonography® technology (zst). this innovative technology provides the platform for the company’s living technology – a constantly evolving architecture to meet the changing imaging needs of the clinician .
in 2008 mindray acquired datascope’s patient monitoring business which offered a wide range of patient monitors in the or, emergency care, and critical care environments for over 50 years. with that acquisition, mindray has become the third - largest player in the north american and global patient monitoring markets, and the third largest supplier of anesthesia systems as well .
mindray north america 800 macarthur blvd. , mahwah, nj 07430 tel: 201. 995. 8000 tel: 800. 288. 2121 (us and canada only) follow us on linked
over the past three years, mindray’s number of employees has grown from 880 in 2003 to over 2, 700 people globally by the end of 2006 ,
states arani .
this rapid expansion of personnel is a testament to mindray’s constant success and acceptance in new markets, and also its commitment in providing gold standard customer support in each geographic area that its products are sold in .
mindray is a focused, innovative, and accessible provider of technologies and solutions for patient monitoring, anesthesia, and ultrasound. it is our mission to set the standard for all others to be measured .
mindray north america is headquartered in mahwah, new jersey, and has large field sales and support teams covering the united states, canada and puerto rico. clinical education specialists provide your staff with comprehensive, on - site product training and in - service. our dedicated field service team and in - house technical support organization represent one of the largest direct service teams in the industry. mindray is fully committed to enhancing patient care while protecting your investment .
continued r & d activities have been another key to mindray’s exceptional success. historically, the company has allocated 10 percent of its total revenues to r & d spending. this attention to innovation has resulted in the introduction of 20 new products from 2003 to 2005 .
there are two engineering centers in north america. the innovation center, located in silicon valley, california, is focused on innovative ultrasound technologies including zone sonography® technology for premium and high end systems. engineering in the new jersey corporate headquarters is primarily focused on the user interface design and user experience for patient monitoring and anesthesia delivery systems .
while improving the quality of patient care, we help reduce its cost by making advanced products more accessible to a broader global community, bringing healthcare within reach .
this award is presented in recognition of the leading chinese patient monitoring manufacturer’s continuous global expansion through competitive pricing and the worldwide presence of its sales and marketing support teams .
the frost & sullivan global excellence award is bestowed each year upon the company which has demonstrated global excellence in a given business function such as sales, marketing, customer service, technology innovation, product quality, supply chain management, and growth strategy. the award recipient has distinguished itself through its proactive global integration strategies that position the company to emerge as a global leader .
best practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. industry analysts compare market participants and measure performance through in - depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry .
, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. the company' s industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities .
serves an extensive clientele that includes global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics. for more information, visit
to receive industry breaking news and analysis sign up for our mailing list. include your full contact details and specify your industry of interest .
for inquiries related to this message please contact support. for sales inquiries, please visit urltoken
if you believe this to be in error, please confirm below that you are not a robot by clicking
i' m not a robot
below .
please make sure your browser supports javascript and cookies and that you are not blocking them from loading. for more information you can review the terms of service and cookie policy .
, among the company, parent and merger sub. as a result of the merger, the company has ceased to be a publicly traded company and became a wholly owned subsidiary of parent .
in cash per share without interest and net of any applicable withholding taxes, other than (x) shares beneficially owned by certain rollover shareholders (the
rollover shares
), (y) shares owned by shareholders who have validly exercised and have not effectively withdrawn or lost their dissenter rights under the cayman islands companies law (the
cicl
) (the
dissenting shares
), and (z) shares represented by american depositary shares, each representing one share (the
adss
). each ads issued and outstanding immediately prior to the effective time of the merger (other than adss representing the rollover shares) has been cancelled in exchange for the right to receive
per ads cancellations fees). the rollover shares have been cancelled for no consideration, and the dissenting shares have been cancelled for payment of their fair value to be determined in accordance with the cicl .
shareholders of record as of the effective time of the merger who are entitled to merger consideration will receive a letter of transmittal and instructions on how to surrender their share certificates in exchange for the merger consideration. shareholders should wait to receive the letter of transmittal before surrendering such certificates. as soon as practicable after the date of this announcement, the bank of new york mellon, in its capacity as the ads depositary (the
depositary
) will call for the surrender of adss (other than ads representing the rollover shares) for delivery of the merger consideration. upon the surrender of adss, the depositary will pay to the surrendering holders
the company also announced today that it requested that trading of its adss on the new york stock exchange (the
nyse
) be suspended. the company requested that the nyse file a form 25 with the u. s. securities and exchange commission (the
sec
) notifying the sec of the delisting of its adss on the nyse and the deregistration of the company' s registered securities. the deregistration will become effective 90 days after the filing of form 25 or such shorter period as may be determined by the sec. the company intends to suspend its reporting obligations under the securities exchange act of 1934, as amended, by filing a form 15 with the sec in approximately ten days. the company' s obligations to file with the sec certain reports and forms, including form 20 - f and form 6 - k, will be suspended immediately as of the filing date of the form 15 and will terminate once the deregistration becomes effective .
skadden, arps, slate, meagher & flom llp is serving as the u. s. legal counsel to mr .
, the executive chairman of the board of directors of the company (the
board
), president and co - chief executive officer of the company, mr .
, the chairman of the board, and mr. cheng minghe, the co - chief executive officer and chief strategic officer of the company (collectively, the
buyer group
) .
this press release may contain forward - looking statements within the meaning of section 27a of the securities act of 1933, as amended, and section 21e of the securities exchange act of 1934, as amended, and as defined in the u. s. private securities litigation reform act of 1995. these forward - looking statements can be identified by terminology such as
if ,
will ,
expected ,
and similar statements. forward - looking statements involve inherent risks, uncertainties and assumptions. these forward - looking statements reflect the company' s expectations as of the date of this press release. you should not rely upon these forward - looking statements as predictions of future events. the company does not undertake any obligation to update any forward - looking statement, except as required under applicable law .
copyright © 2018 pr newswire association llc. all rights reserved. a cision company.
mindray medical international limited is china 's largest medical equipment manufacturer , developing , manufacturing , and marketing a variety of medical devices , equipment and accessories for both human and veterinary use . the company is currently organized into three key business lines : patient monitoring & life support , in-vitro diagnostic products , and medical imaging systems . headquartered in shenzhen , china , mindray possesses a sound r&d , marketing and service network with 41 subsidiaries and branch offices in 31 countries in north and latin america , europe , africa and asia-pacific , as well as 32 branch offices in china . to date , mindray has around 8200 employees around the world . its north american headquarters are located in mahwah , new jersey . the patient monitoring & life support division develops and manufactures multi-parameter patient monitors , biotelemetry systems , anesthesia delivery systems , defibrillators , ecg machines , pulse oxymeters , hospital beds , mounting systems and it solutions for customers worldwide . in 2008 , mindray purchased the patient monitoring division of datascope corporation for $ 209 million to expand their presence outside of china . the in-vitro diagnostic division provides data and analysis on blood , urine , and other bodily fluid samples for clinical diagnosis and treatment . this segment offers a range of semi-automated and fully automated diagnostic laboratory instruments for laboratories , clinics , and hospitals . its products include hematology analyzers , biochemistry analyzers , reagents , a microplate reader and a microplate washer . 
mindray medical international limited is china's largest medical equipment manufacturer, developing, manufacturing, and marketing a variety of medical devices, equipment and accessories for both human and veterinary use. the company is currently organized into three key business lines: patient monitoring & life support, in-vitro diagnostic products, and medical imaging systems. headquartered in shenzhen, china, mindray possesses a sound r&d, marketing and service network with 41 subsidiaries and branch offices in 31 countries in north and latin america, europe, africa and asia-pacific, as well as 32 branch offices in china. to date, mindray has around 8200 employees around the world. its north american headquarters are located in mahwah, new jersey. the patient monitoring & life support division develops and manufactures multi-parameter patient monitors, biotelemetry systems, anesthesia delivery systems, defibrillators, ecg machines, pulse oxymeters, hospital beds, mounting systems and it solutions for customers worldwide. in 2008, mindray purchased the patient monitoring division of datascope corporation for $ 209 million to expand their presence outside of china. the in-vitro diagnostic division provides data and analysis on blood, urine, and other bodily fluid samples for clinical diagnosis and treatment. this segment offers a range of semi-automated and fully automated diagnostic laboratory instruments for laboratories, clinics, and hospitals. its products include hematology analyzers, biochemistry analyzers, reagents, a microplate reader and a microplate washer.
mindray medical international limited is china's largest medical equipment manufacturer, developing, manufacturing, and marketing a variety of medical devices, equipment and accessories for both human and veterinary use. the company is currently organized into three key business lines: patient monitoring & life support, in-vitro diagnostic products, and medical imaging systems. headquartered in shenzhen, china, mindray possesses a sound r&d, marketing and service network with 41 subsidiaries and branch offices in 31 countries in north and latin america, europe, africa and asia-pacific, as well as 32 branch offices in china. to date, mindray has around 8200 employees around the world. its north american headquarters are located in mahwah, new jersey. the patient monitoring & life support division develops and manufactures multi-parameter patient monitors, biotelemetry systems, anesthesia delivery systems, defibrillators, ecg machines, pulse oxymeters, hospital beds, mounting systems and it solutions for customers worldwide. in 2008, mindray purchased the patient monitoring division of datascope corporation for $ 209 million to expand their presence outside of china. the in-vitro diagnostic division provides data and analysis on blood, urine, and other bodily fluid samples for clinical diagnosis and treatment. this segment offers a range of semi-automated and fully automated diagnostic laboratory instruments for laboratories, clinics, and hospitals. its products include hematology analyzers, biochemistry analyzers, reagents, a microplate reader and a microplate washer.